Status:
UNKNOWN
GABA Antagonist to Improve Reversal of Anesthesia With High-density EEG Surveillance
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Moderate Sedation
Colonoscopy
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
For recent years, patients are more likely to accept sedation during endoscopic examination due to better quality and experience. Modest anesthetic state for different kind of procedure is important, ...
Eligibility Criteria
Inclusion
- ASA I or II
- plan to do colonoscopy
Exclusion
- existed CNS disease or injuries
- known allergy to propofol, midazolam or alfentanil
Key Trial Info
Start Date :
March 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04329585
Start Date
March 25 2020
End Date
March 31 2022
Last Update
April 1 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100
2
National Taiwan University Cancer Center
Taipei, Taiwan, 106